214 - The Ongoing Process of Determining COVID-19 Vaccines Safety - a podcast by Johns Hopkins Bloomberg School of Public Health

While clinical trials are a “gold standard” to indicate if a vaccine’s benefits outweigh its risks, safety monitoring doesn’t stop there. Dr. Daniel Salmon, director of the Johns Hopkins Institute for Vaccine Safety, helped lead federal efforts to monitor the H1N1 vaccine’s safety once it became widely used in 2009. Dr. Salmon talks with Stephanie Desmon about what goes into monitoring a vaccine for safety.

Further episodes of Public Health On Call

Further podcasts by Johns Hopkins Bloomberg School of Public Health

Website of Johns Hopkins Bloomberg School of Public Health